Efficacy of Short-message-based Re-education (SMRE) on Helicobacter Pylori Eradication

Helicobacter Pylori Eradication Rate Clinical Trial

Official title:
Efficacy of Short-message-based Re-education (SMRE) on Helicobacter Pylori Eradication

Status Recruiting

Clinical Trial Summary

Helicobacter pylori (H. pylori) is a pathogen that infects more than 50% of the human population, resulting in high healthcare costs worldwide. However, H. pylori eradication rate is low nowadays and patients's compliance is one of the most important effective factors.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Helicobacter Pylori Eradication Rate

Clinical Trial Details

NCT number	NCT02833623
Study type	Interventional
Source	Shandong University
Contact	Yanqing Li, MD,PhD
Phone	86-531-82169236
Email	liyanqing@sdu.edu.cn
Status	Recruiting
Phase	Phase 4
Start date	October 2016
Completion date	January 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02776371` - Modified Non-clarithromycin Triple Therapy in Eradicating Helicobacter Pylori	Phase 4
Not yet recruiting	`NCT05196945` - Vonoprazan Fumarate in Combination With Amoxicillin for the First-line Eradication of Helicobacter Pylori -- a Multicenter, Randomized, Parallel Controlled Study	Phase 4
Completed	`NCT05719831` - Optimization of Vonoprazan--amoxicillin Dual Therapy for Eradicating Helicobacter Pyloriinfection	Phase 3